Scientists dive deep into thymic tumors to unlock new clues

NCT ID NCT05558644

Recruiting now Knowledge-focused Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study looks at thymic epithelial tumors, a rare type of cancer in the chest. Researchers will collect tumor and blood samples from 50 patients during surgery to analyze the immune cells and genetic changes in the tumors. The goal is to better understand the disease and identify possible targets for future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could reveal new genetic targets for treating thymic epithelial tumors, potentially leading to better therapies.
What could go wrong: This is an early observational study with only 50 participants, so findings may not apply to all patients. It is not testing a treatment, so no direct benefit is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm thymic epithelial neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Hôpital FOCH
RECRUITING

Suresnes, France
Institut Curie Paris
RECRUITING

Paris, France
Institut Mutualiste Montsouris
RECRUITING

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.